Geneos Wealth Management’s abrdn Healthcare Investors HQH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28K | Hold |
72
| – | – | ﹤0.01% | 2372 |
|
|
2025
Q4 | $1.36K | Hold |
72
| – | – | ﹤0.01% | 2374 |
|
|
2025
Q3 | $1.33K | Sell |
72
-2,821
| -98% | -$46.1K | ﹤0.01% | 2374 |
|
|
2025
Q2 | $44.8K | Buy |
2,893
+2,769
| +2,233% | +$42.9K | ﹤0.01% | 1632 |
|
|
2025
Q1 | $2.01K | Buy |
+124
| New | +$2.13K | ﹤0.01% | 2970 |
|
|
2024
Q4 | – | Sell |
-31
| Closed | -$577 | – | 2923 |
|
|
2024
Q3 | $577 | Hold |
31
| – | – | ﹤0.01% | 2536 |
|
|
2024
Q2 | $541 | Hold |
31
| – | – | ﹤0.01% | 2048 |
|
|
2024
Q1 | $523 | Hold |
31
| – | – | ﹤0.01% | 2118 |
|
|
2023
Q4 | $514 | Buy |
+31
| New | +$477 | ﹤0.01% | 2088 |
|
|
2023
Q3 | – | Sell |
-35
| Closed | -$597 | – | 2116 |
|
|
2023
Q2 | $597 | Hold |
35
| – | – | ﹤0.01% | 2056 |
|
|
2023
Q1 | $618 | Hold |
35
| – | – | ﹤0.01% | 2032 |
|
|
2022
Q4 | $630 | Hold |
35
| – | – | ﹤0.01% | 2004 |
|
|
2022
Q3 | $0 | Sell |
35
-889
| -96% | -$17K | ﹤0.01% | 2270 |
|
|
2022
Q2 | $17K | Buy |
924
+20
| +2% | +$395 | ﹤0.01% | 1749 |
|
|
2022
Q1 | $18K | Sell |
904
-10
| -1% | -$212 | ﹤0.01% | 1850 |
|
|
2021
Q4 | $21K | Buy |
914
+14
| +2% | +$349 | ﹤0.01% | 1858 |
|
|
2021
Q3 | $22K | Buy |
900
+30
| +3% | +$789 | ﹤0.01% | 1877 |
|
|
2021
Q2 | $22K | Hold |
870
| – | – | ﹤0.01% | 1871 |
|
|
2021
Q1 | $21K | Sell |
870
-583
| -40% | -$14.2K | ﹤0.01% | 2057 |
|
|
2020
Q4 | $35K | Sell |
1,453
-1,835
| -56% | -$39.9K | ﹤0.01% | 1628 |
|
|
2020
Q3 | $66K | Buy |
3,288
+10
| +0.3% | +$211 | ﹤0.01% | 1122 |
|
|
2020
Q2 | $68K | Buy |
3,278
+48
| +1% | +$978 | ﹤0.01% | 1084 |
|
|
2020
Q1 | $55K | Buy |
3,230
+28
| +0.9% | +$552 | ﹤0.01% | 1073 |
|
|
2019
Q4 | $67K | Buy |
3,202
+819
| +34% | +$16.2K | ﹤0.01% | 1112 |
|
|
2019
Q3 | $43K | Sell |
2,383
-3
| -0.1% | -$58 | ﹤0.01% | 1261 |
|
|
2019
Q2 | $47K | Sell |
2,386
-727
| -23% | -$14.4K | ﹤0.01% | 1222 |
|
|
2019
Q1 | $63K | Buy |
3,113
+59
| +2% | +$1.21K | ﹤0.01% | 1028 |
|
|
2018
Q4 | $54K | Sell |
3,054
-246
| -7% | -$5.03K | ﹤0.01% | 1055 |
|
|
2018
Q3 | $76K | Buy |
3,300
+46
| +1% | +$1.04K | 0.01% | 984 |
|
|
2018
Q2 | $69K | Sell |
3,254
-61
| -2% | -$1.3K | 0.01% | 914 |
|
|
2018
Q1 | $71K | Buy |
3,315
+838
| +34% | +$19.3K | 0.01% | 866 |
|
|
2017
Q4 | $55K | Buy |
2,477
+103
| +4% | +$2.41K | ﹤0.01% | 961 |
|
|
2017
Q3 | $59K | Sell |
2,374
-1,195
| -33% | -$30K | 0.01% | 886 |
|
|
2017
Q2 | $89K | Buy |
3,569
+58
| +2% | +$1.44K | 0.01% | 721 |
|
|
2017
Q1 | $84K | Buy |
3,511
+13
| +0.4% | +$305 | 0.01% | 714 |
|
|
2016
Q4 | $73K | Buy |
3,498
+57
| +2% | +$1.27K | 0.01% | 699 |
|
|
2016
Q3 | $81K | Sell |
3,441
-285
| -8% | -$7.17K | 0.01% | 648 |
|
|
2016
Q2 | $89K | Sell |
3,726
-641
| -15% | -$15.9K | 0.01% | 626 |
|
|
2016
Q1 | $107K | Buy |
+4,367
| New | +$104K | 0.02% | 560 |
|
Other funds holding HQH
PCM
AAM
NIM
ZCP
Geneos Wealth Management's HQH Position: Q1 2026 in Review
Geneos Wealth Management held its abrdn Healthcare Investors (HQH) position steady in Q1 2026 at 72 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2372.
Geneos Wealth Management first reported a position in HQH in Q1 2016 and has held it in 39 quarters since. The position peaked at $107K in Q1 2016. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.
- Geneos Wealth Management held 72 shares of abrdn Healthcare Investors worth $1.28K as of Q1 2026.
- Geneos Wealth Management left its abrdn Healthcare Investors share count unchanged in Q1 2026.
- abrdn Healthcare Investors made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2372 holding.
- Geneos Wealth Management first reported a position in abrdn Healthcare Investors in Q1 2016 and has held it in 39 quarters since.
- Geneos Wealth Management's abrdn Healthcare Investors position peaked at $107K in Q1 2016.
- 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.